Harvest Group Wealth Management, LLC Cellectis S.A. Transaction History

Harvest Group Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$18.19 - $33.25 $5,638 - $10,307	-310 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$8.21 - $21.02 $2,545 - $6,516	310 New	310 $5,000
Q4 2019 Jan 27, 2020	SELL	$9.73 - $19.31 $4,826 - $9,577	-496 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$14.6 - $20.6 $832 - $1,174	57 Added 12.98%	496 $7,000
Q1 2019 May 06, 2019	BUY	$15.53 - $19.75 $6,817 - $8,670	439 New	439 $8,000

11.2M

2.8K

17.9K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $82.8M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Harvest Group Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Group Wealth Management, LLC with notifications on news.